Current share price:  LSE: £1888.00   -0.63%



Quarterly pro forma translated results fiscal 2009

Fiscal 2009 US GAAP Quarterly Financial Statements

Income Statement
Segmental information
Balance Sheet
Cash flow

Income Statement
 
Q1
$m
Q2
$m
Q3
$m
 Q4
$m
Full year
$m 
Sales
Cost of sales
822.5
(544.8)
768.9
(519.8)
 629.3
(454.5)
 1,123.6
(745.1)
 3,344.3
(2,264.2)
Gross margin277.7249.1 174.8 378.5 1,080.1
Selling, general and administrative expenses(261.7)(229.9)(217.3)(260.3)(969.2)
Other operating income, net29.928.828.332.2119.2
Impairment of goodwill---(516.9)(516.9)
Relisting costs-(10.5)--(10.5)
Operating income/(loss)
Interest income
Interest expense
45.9
1.7
(7.5)
37.5
0.8
(7.7)
(14.2)
0.6
(10.0)
(366.5)
0.5
(7.6)
(297.3)
3.6
(32.8)
Income/(loss) before income taxes
Income taxes
40.1
(14.4)
30.6
(10.9)
(23.6)
8.5
(373.6)
(50.4)
(326.5)
(67.2)
Net income/(loss)25.719.7(15.1)(424.0)(393.7)
      
Earnings/(loss) per share*
   - basic
   - diluted

$0.30
$0.30

$0.23
$0.23

$(0.18)
$(0.18)

$(4.97)
$(4.97)

$(4.62)
$(4.62)

* Adjusted for the 1 for 20 share consolidation undertaken as part of the move of the primary listing of the parent company's shares, effective September 11, 2008.

Segmental Information
 Q1
$m
Q2
$m
Q3
$m
Q4
$m
Full year
$m
Sales
US
UK

631.1
191.4

575.6
193.3

467.3
162.0

862.1
261.5

2,536.1
808.2
 822.5768.9629.31,123.63,344.3
Operating income/(loss)
US
UK
Unallocated1

46.7
3.5
(4.3)

50.2
2.3
(15.0)

(6.2)
(3.9)
(4.1)

(327.1)
(39.3)
(0.1)

(236.4)
(37.4)
(23.5)
 45.937.5(14.2)(366.5)(297.3)
1 Unallocated principally relates to central group costs.

 

Balance Sheet
 Q1
$m
Q2
$m
Q3
$m
Q4
$m
Full year
$m
Assets:
Current assets
     
Cash and cash equivalents29.266.935.596.896.8
Accounts receivable, net787.4760.8718.6825.2825.2
Other receivables33.527.025.881.881.8
Other current assets25.946.344.445.045.0
Deferred tax assets--0.3--
Inventories1,516.01,454.51,552.71,364.41,364.4
Total current assets 2,392.02,355.52,377.32,413.22,413.2
Non-current assets     
Property, plant and equipment, net491.0498.7477.7452.1452.1
Goodwill556.7556.0529.6--
Intangible assets, net22.022.823.123.923.9
Other assets40.541.141.49.99.9
Retirement benefit asset-----
Deferred tax assets76.274.868.054.854.8
 1,186.41,193.41,139.8540.7540.7
Total assets3,578.43,548.93,517.12,953.92,953.9

Liabilities and shareholders' equity:
Current liabilities
     
Loans and overdrafts26.2120.2233.3187.5187.5
Accounts payable100.382.5121.542.242.2
Accrued expenses and other current liabilities229.8231.4235.3274.8274.8
Deferred revenue115.8106.3103.6120.1120.1
Deferred tax liabilities55.053.149.256.956.9
Income taxes payable65.159.332.655.855.8
Total current liabilities592.2652.8775.5737.3737.3
Non-current liabilities     
Long-term debt380.0380.0380.0380.0380.0
Other liabilities109.9102.5111.371.571.5
Deferred revenue140.8147.8130.4142.5142.5
Retirement benefit obligation4.64.02.812.912.9
 635.3634.3624.5606.9606.9
Total liabilities 1,227.51,287.11,400.01,344.21,344.2
      
Total  shareholders' equity2,350.92,261.82,117.11,609.71,609.7
      
Total  liabilities and shareholders' equity3,578.43,548.93,517.12,953.92,953.9

 

Cash Flow
 Q1
$m
Q2
$m
Q3
$m
Q4
$m
Full year
$m
Cash flows from operating activities:     
Net income/(loss)25.719.7(15.1)(424.0)(393.7)
Adjustments for:     
Depreciation of property, plant and equipment27.125.527.727.8108.1
Amortisation of intangible assets1.31.51.42.26.4
Impairment of goodwill---516.9516.9
Pension expense/(income)0.20.30.3(0.6)0.2
Stock-based compensation expense/(income)0.30.40.1(0.1)0.7
Deferred taxation(1.5)-6.619.624.7
Other non-cash movements(4.2)1.41.4(1.4)(2.8)
(Profit)/loss on disposal of property, plant and equipment(0.3)0.4-(0.8)(0.7)
Changes in operating assets and liabilities:
(Increase)/decrease in inventories

(48.7)

58.1

(156.9)

160.2

12.7
Decrease in accounts receivables62.024.043.1(108.6)20.5
(Increase)/decrease in other receivables(1.1)(5.9)1.8(13.0)(18.2)
Decrease/(increase) in other current assets2.00.7(4.5)3.21.4
Increase/(decrease) in trade payables8.8(21.6)55.8(81.0)(38.0)
Accrued expenses and other liabilities(30.0)6.02.126.76.1
Deferred revenue(9.6)(11.4)(9.5)22.0(9.8)
(Decrease)/increase in income taxes payable(10.0)(6.1)(28.1)23.7(20.5)
Effect of exchange rates on currency swaps(0.4)1.6(43.7)(7.5)(49.6)
Net cash provided by operating activities21.694.6(117.5)165.3164.4

Investing activities:
     
Purchase of property, plant and equipment(25.1)(38.0)(28.0)(14.0)(105.1)
Purchase of other intangible assets(1.3)(2.3)(2.7)(3.5)(9.8)
Proceeds from sale of property, plant and equipment1.0--0.61.6
Net cash flows used in investing activities (25.4)(40.3)(30.7)(16.9)(113.3)

Financing activities:
     
Dividends paid-(107.4)-(16.4)(123.8)
Proceeds from issue of common stock---0.10.1
(Decrease)/increase in short-term borrowings(10.4)94.1116.0(39.1)
160.6
Net cash flows used in financing activities(10.4)(13.3)116.0(55.4)36.9
Cash and cash equivalents at beginning of period41.729.266.935.541.7
(Decrease)/increase in cash and cash equivalents(14.2)41.0(32.2)93.088.0
Effect of exchange rate changes on cash and cash equivalents1.7(3.3)0.8(31.7)(32.9)
Cash and cash equivalents at end of period29.266.935.596.896.8

Developed by global3digital